History
The Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” (IRST IRCCS) was founded in 2007 in its main headquarters in Meldola, inside the former Civil Hospital. The operational offices were then activated at the hospital facilities “Morgagni-Pierantoni” in Forlì, “Bufalini” in Cesena and “Santa Maria delle Croci” in Ravenna.
IRST IRCCS is part of the National Health Service of the Emilia-Romagna Region and is the promoter with the local health authority – AUSL Romagna – of the Comprehensive Cancer Care and Research Network (CCCRN) project. The CCCRN is a path of collaboration and integration between institutions for the creation of an oncology network which accompanies patients throughout their treatment path and giving strength to research. The institute has been recognised as a Scientific Research Institute for the Treatment and Research on Tumors (IRCCS) by the Italian Ministry of Health since March 2012.
The Istituto Romagnolo per lo Studio e la Cura dei Tumori "Dino Amadori" – (IRST IRCCS) is entirely dedicated to treatment, clinical, biological and translational research and training in the oncology field.
Profile
The Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" manages hospitalisation and treatment activities in the oncology sector in line with national, regional and territorial planning. Within the CCCRN, the IRST carries out governance activities for oncology research and clinical trials. The main site has 36 beds, entirely dedicated to Onco-haematology, divided into ordinary hospitalisation, low microbial load and radiometabolic rooms. Three Day Hospital/Day service units are also active (central office, Cesena office and Forlì office) alongside the outpatient activity.
Specialities
The centre provides treatment for gastric and intestinal, gynaecological, neuroendocrine and endocrine gland, bone, skin, pulmonary and thoracic, prostate, testicular and urological, breast, head and neck, and other tumors - rare, sarcomas, leukaemia, myeloma and haematological, melanoma, for which the oncologists and haematologists are responsible for coordinated care activities and clinical research. A characteristic of the Institute is the division of the clinicians' skills into multidisciplinary pathology groups in which several professional figures collaborate, such as biologists, study coordinators and dedicated pharmacists.
Palliative and Supportive Care
In 2022, the palliative care team found its new structure, becoming SSD Palliative Care, Pain Therapy and Integrated Medicine. It belongs to the Department of Clinical and Experimental Oncology and Hematology and is the Outpatient - Hospital Consultation node of the Local Palliative Care Network of Romagna. It is currently composed of palliative physicians, Case Managers and Research Nurses in Palliative Care, psycho-oncologists, nutritionists.
The mission of the SSD is to integrate support activities (Palliative Care, Pain Therapy, Psycho-oncology, Nutrition and Integrated Medicine) to ensure complete assistance to the cancer patient and their caregivers in all phases of the healing process and the disease, from prevention to active cancer treatment, up to the end-of-life and survivorship.
Onco-hematological patients have their palliative care needs taken care of by the SSD through palliative care, pain therapy and integrative medicine which:
- carries out specialist consultancy activities through hospitalisation and day hospital/day service and within the relevant outpatient clinic for early palliative care, through palliative doctors.
- makes use of the collaboration of nurses for the assistance and treatment of pain in all care settings.
- coordinates "protected discharges" from hospital and/or day hospital to the territory (regional or extra-regional) through the activation of home care or through transfer to territorial hospices.
- manages the integrated Radiotherapy and Palliation clinic, in collaboration with radiotherapists.
- participates in multidisciplinary activities for which specific consultancy is required.
Last update: October 2024
